A fictional 63-year-old receiving systemic anticancer treatment presents with rigors, new confusion and hypotension ten days after the latest cycle.
Frame the danger first.
- Suspect neutropenic sepsis in an unwell person receiving anticancer treatment, even without a high temperature.
- Establish treatment dates, regimen, central access, prophylaxis and prior resistant organisms.
- Do not rely on a pending neutrophil count to decide whether urgent assessment and treatment are needed.
Act, escalate, reassess.
- Activate the local neutropenic-sepsis pathway and escalate immediately.
- Perform ABCDE assessment, obtain cultures and essential investigations without delaying protocol-directed antibiotics.
- Use current local antimicrobial guidance, allergy history and prior microbiology.
- Seek acute oncology/haematology and critical-care input according to severity and response.
Red flags that change pace.
- Shock, altered consciousness, hypoxia or rapidly worsening physiology
- High-risk treatment, profound/prolonged neutropenia or significant comorbidity
- Central-line complication, resistant organism risk or clinical deterioration despite treatment
What makes care less safe.
- Waiting for fever or the full blood count before acting
- Delaying antibiotics for non-essential investigations
- Assuming a low-risk score can override instability
Say the concern plainly.
Suspected neutropenic sepsis after [treatment/date], with [physiological concern]. Cultures/investigations are [status] and local empiric treatment was started at [time]. I need urgent oncology/haematology and senior review for [severity/source/non-response].